Literature DB >> 14927431

Phenylbutazone (butazolidin) in rheumatoid arthritis and gout.

W C KUZELL, R W SCHAFFARZICK, B BROWN, E A MANKLE.   

Abstract

Entities:  

Keywords:  ANALGESICS; ARTHRITIS, RHEUMATOID/therapy; GOUT/therapy

Mesh:

Substances:

Year:  1952        PMID: 14927431     DOI: 10.1001/jama.1952.02930250011004

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  14 in total

1.  The effect of phenylbutazone on uric acid metabolism in two normal subjects.

Authors:  J B WYNGAARDEN
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

2.  Metabolic effect of phenylbutazone in gouty and non-gouty arthritis.

Authors:  E R HUFFMAN; G M WILSON; C J SMYTH; R HILL
Journal:  Ann Rheum Dis       Date:  1954-12       Impact factor: 19.103

3.  BENEFITS and dangers of butazolidin.

Authors: 
Journal:  Br Med J       Date:  1952-12-27

4.  Comparative effects of ACTH and butazolidin in rheumatoid arthritis.

Authors:  R M MASON
Journal:  Ann Rheum Dis       Date:  1953-06       Impact factor: 19.103

5.  Observations on the treatment of rheumatoid arthritis with butazolidin.

Authors:  J P CURRIE; R A BROWN; G WILL
Journal:  Ann Rheum Dis       Date:  1953-06       Impact factor: 19.103

6.  Toxic effects of phenylbutazone.

Authors:  J R NASSIM; T PILKINGTON
Journal:  Br Med J       Date:  1953-06-13

Review 7.  Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?

Authors:  Ted R Mikuls; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

8.  Multiple visceral lesions due o phenylbutazone toxicity.

Authors:  J R NASSIM
Journal:  Br Med J       Date:  1954-10-30

9.  Pyrazolidines in the treatment of gout.

Authors:  W C Kuzell
Journal:  Can Med Assoc J       Date:  1968-11-30       Impact factor: 8.262

10.  Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects.

Authors:  T F YU; J H SIROTA; A B GUTMAN
Journal:  J Clin Invest       Date:  1953-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.